Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000557400 | SCV000658559 | pathogenic | Familial hyperkalemic periodic paralysis | 2022-07-12 | criteria provided, single submitter | clinical testing | This missense change has been observed in individuals with autosomal recessive congenital myopathy (PMID: 28262468, 30283817). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects SCN4A function (PMID: 28262468, 30283817). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 477417). This variant is present in population databases (rs780703403, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1142 of the SCN4A protein (p.Arg1142Gln). |
OMIM | RCV003227493 | SCV003924068 | pathogenic | Congenital myopathy 22A, classic | 2024-07-16 | no assertion criteria provided | literature only |